Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs35327698 | chr3:172471102 | G/T | 5.36E-5 | 133 | 42.1 | 41.92 | 47.38 | KM Plot |
| TGCT | rs35333149 | chr7:127778236 | T/TAAA | 2.16E-9 | 133 | 42.1 | 42.15 | 12.55 | KM Plot |
| TGCT | rs35336279 | chr19:37952215 | CTT/C | 5.97E-7 | 133 | 45.47 | 37.53 | 17.48 | KM Plot |
| TGCT | rs35354193 | chr7:128727794 | G/A | 2.02E-5 | 132 | 42.18 | 37.1 | 17.1 | KM Plot |
| TGCT | rs35414340 | chr7:128723194 | C/T | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs35420742 | chr3:172489940 | G/A | 5.36E-5 | 132 | 42.1 | 46.3 | 47.38 | KM Plot |
| TGCT | rs35421489 | chr13:100283620 | T/G | 1.85E-5 | 127 | 36.37 | 47.52 | 45.83 | KM Plot |
| TGCT | rs35445794 | chr3:172563289 | A/T | 7.16E-7 | 132 | 42.18 | 52.08 | 24.15 | KM Plot |
| TGCT | rs35518304 | chr7:128732319 | C/T | 2.04E-5 | 132 | 42.27 | 32.95 | 17.1 | KM Plot |
| TGCT | rs35521928 | chr12:107132808 | AT/A | 3.98E-12 | 134 | 41.97 | 49.93 | 24.27 | KM Plot |
| TGCT | rs35540940 | chr19:38008235 | G/A | 1.39E-13 | 134 | 46.3 | 35.37 | 17.1 | KM Plot |
| TGCT | rs35552227 | chr7:128622088 | C/CT | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs35563200 | chr17:691685 | T/TA | 6.84E-5 | 132 | 20.6 | 25.47 | 45.83 | KM Plot |
| TGCT | rs35644760 | chr2:3488871 | C/T | 2.43E-5 | 131 | 39.38 | 74.47 | 25.32 | KM Plot |
| TGCT | rs35754677 | chr13:21847842 | C/CA | 1.26E-6 | 130 | 46.77 | 36.1 | 14.42 | KM Plot |